The Hayes Critical Analysis Series (CAS) provides clients with customized analyses that respond to their individual business and/or clinical needs. These reports are designed to support strategic planning efforts and technology acquisition decisions, and are complementary to other Hayes reports that provide detailed information about specific technologies. The CAS is comprised of two kinds of reports:

• Comparison Reports address the relative safety, efficacy, and cost impact of multiple competing technologies.
• Financial Impact Analysis provide financial analysis tools in conjunction with a series of unbiased, evidence-based health technology assessments that allow clients to predict the financial impact of a particular healthcare technology acquisition or to evaluate the profitability of a technology currently in use.